Literature DB >> 895533

Hepatic lipid metabolism in severe human obesity.

J G Kral, K Lundholm, P Björntorp, L Sjöström, T Scherstén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 895533     DOI： 10.1016/0026-0495(77)90020-8

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew Paul DeFilippis; Michael J Blaha; Seth S Martin; Robert M Reed; Steven R Jones; Khurram Nasir; Roger S Blumenthal; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2013-01-29       Impact factor: 5.162

2.  Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance.

Authors:  E J Parks; R M Krauss; M P Christiansen; R A Neese; M K Hellerstein
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

3.  Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity.

Authors:  Natascha Potoczna; Ruth Branson; John G Kral; Grazyna Piec; Rudolf Steffen; Thomas Ricklin; Margret R Hoehe; Klaus-Ulrich Lentes; Fritz F Horber
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  Mechanism and treatment of hypertriglyceridaemia in gout.

Authors:  T Gibson; K Kilbourn; I Horner; H A Simmonds
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

5.  [Enzymatic changes and protein metabolism in the early and late postoperative phase during intravenous feeding].

Authors:  M Georgieff; H Lutz
Journal:  Z Ernahrungswiss       Date:  1981-12

6.  A pilot study of metabolic fitness effects of weight-supported walking in women with obesity.

Authors:  Ellen M Godwin; Anthony D Uglialoro; Andaleeb Ali; Leah Yearwood; Mary Ann Banerji; John G Kral
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

Review 7.  Platelets in Non-alcoholic Fatty Liver Disease.

Authors:  Andrea Dalbeni; Marco Castelli; Mirko Zoncapè; Pietro Minuz; David Sacerdoti
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.